Le Lézard1h
RSI Security Authorized as a C3PAO by the Cyber-AB to Conduct CMMC Assessments
RSI Security, a leader in cybersecurity compliance and risk management, is proud to announce its authorization as a Certified Third-Party Assessor Organization (C3PAO) by the Cybersecurity Maturity ...
Le Lézard2h
Marble Visions Initiates Development of 3D Earth Observation Satellite System in Joint Venture with NTT DATA, PASCO, and Canon Electronics
NTT DATA, a global digital business and IT services leader, and Marble Visions Inc., a provider of advanced Earth observation(EO) satellite services, today announce that Marble Visions has commenced ...
Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer ...
Measles outbreak in Southwest sickens nearly 100 people
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Measles oubreak sickens dozens in Texas, New MexicoAn outbreak of measles is wreaking havoc in the ...
Pfizer sets sights on Summit’s bispecific in combo with its ADCs
Summit’s PD-1 bispecific antibody outperformed MSD’s Keytruda in a Phase III trial enrolling patients with lung cancer.
Pfizer taps former FDA drug chief as chief medical officer
Pfizer (NYSE:PFE) has tapped Patrizia Cavazzoni, the former head of drug regulation at the FDA, as its new chief medical ...
Summit Therapeutics advances ivonescimab with Pfizer collaboration and expanded trials
Discover insights from Summit Therapeutics' Q4 2024 earnings call, highlighting the Pfizer collaboration, ivonescimab trial expansions, and strong ...
Summit Therapeutics Shares Down as 4Q Loss Widens
Summit Therapeutics shares fell after the company reported a wider loss in the fourth quarter. Shares were trading 14% lower at $19.11. The biopharmaceutical oncology company reported a loss of $61.2 ...
Summit Therapeutics to test lead cancer drug with Pfizer ADCs
Summit Therapeutics (NASDAQ:SMMT) has entered a clinical trial collaboration to evaluate its cancer drug, ivonescimab, in combination with Pfizer (NYSE:PFE) antibody drug conjugates across multiple ...
Pfizer: What The Summit Therapeutics Deal Brings
Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...
pharmaphorum13h
FDA looks at Opdivo/Yervoy in first-line colorectal cancer
The FDA has started a priority review of Bristol Myers Squibb's Opdivo and Yervoy as a first-line therapy for patients with a ...
Joplin Globe13h
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the TD Cowen 45 th Annual Health ...